| Mustafa Eldadah, MD | |
|
330 Laurel St, Suite 2100, Des Moines, IA 50314-3034 | |
| (515) 643-8611 | |
| (515) 643-8812 |
| Full Name | Mustafa Eldadah |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 330 Laurel St, Des Moines, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306954516 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD-33656 (Iowa) | Primary |
| Entity Name | Mercy Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457691941 PECOS PAC ID: 7911810882 Enrollment ID: O20031112000238 |
News Archive
CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today that the U.S. Food and Drug Administration (FDA) has indicated that the Company can proceed with its first clinical trial to evaluate the effect of its investigational LEAPS-H1N1 treatment on the white blood cells of hospitalized H1N1 patients.
Antimicrobial compounds added to preserve food during storage are believed to be benign and non-toxic to the consumer, but there is "a critical scientific gap in understanding the potential interactions" they may have with the hundreds of species of microbes in our intestines, say David Sela, a nutritional microbiologist at the University of Massachusetts Amherst, and colleagues.
International Partnership for Microbicides (IPM) today announced that it has reached a farsighted agreement with Tibotec Pharmaceuticals Ltd, a subsidiary of Johnson & Johnson. The aim is to develop the promising compound TMC120 as a safe and effective microbicide to help protect women from infection with HIV. This agreement marks the first collaboration in the microbicide field between a major healthcare company and a public-private partnership such as IPM.
Researchers at the Hebrew University of Jerusalem have discovered that a neuronal pathway - part of the autonomic nervous system - reaches the bones and participates in the control of bone development.
Members of the media are invited to attend a press availability period at noon on Friday, December 18, 2009 that will follow a scientific meeting evaluating the safety of soy infant formula. An independent panel of 14 scientists will evaluate the most current research on soy infant formula to determine whether exposure to soy infant formula is a risk to human development.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mustafa Eldadah, MD Po Box 1475, Des Moines, IA 50305-1475 Ph: (515) 643-8611 | Mustafa Eldadah, MD 330 Laurel St, Suite 2100, Des Moines, IA 50314-3034 Ph: (515) 643-8611 |
News Archive
CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today that the U.S. Food and Drug Administration (FDA) has indicated that the Company can proceed with its first clinical trial to evaluate the effect of its investigational LEAPS-H1N1 treatment on the white blood cells of hospitalized H1N1 patients.
Antimicrobial compounds added to preserve food during storage are believed to be benign and non-toxic to the consumer, but there is "a critical scientific gap in understanding the potential interactions" they may have with the hundreds of species of microbes in our intestines, say David Sela, a nutritional microbiologist at the University of Massachusetts Amherst, and colleagues.
International Partnership for Microbicides (IPM) today announced that it has reached a farsighted agreement with Tibotec Pharmaceuticals Ltd, a subsidiary of Johnson & Johnson. The aim is to develop the promising compound TMC120 as a safe and effective microbicide to help protect women from infection with HIV. This agreement marks the first collaboration in the microbicide field between a major healthcare company and a public-private partnership such as IPM.
Researchers at the Hebrew University of Jerusalem have discovered that a neuronal pathway - part of the autonomic nervous system - reaches the bones and participates in the control of bone development.
Members of the media are invited to attend a press availability period at noon on Friday, December 18, 2009 that will follow a scientific meeting evaluating the safety of soy infant formula. An independent panel of 14 scientists will evaluate the most current research on soy infant formula to determine whether exposure to soy infant formula is a risk to human development.
› Verified 2 days ago
Catherine P Mcneill, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6611 Fax: 515-241-6635 | |
Dr. Lisa I Hardisty, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-5926 Fax: 515-241-5127 | |
Dr. Theresa Marie Wahlig, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-8409 | |
Dr. Basaviah Chandramouli, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 330 Laurel St, Suite 2200, Des Moines, IA 50314 Phone: 515-288-1097 Fax: 515-288-2847 | |
Holley A Bzdega, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 Pleasant St, Neonatology, Des Moines, IA 50309 Phone: 515-241-4444 Fax: 515-241-5127 | |
Richard S Robus, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1221 Pleasant St, Suite 170, Des Moines, IA 50309 Phone: 515-241-4300 Fax: 515-241-4359 | |
Bradley J Riley, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Neonatology, Des Moines, IA 50309 Phone: 515-241-5926 Fax: 515-241-5127 |